Breast Milk Safety Study of an Antibiotic for Nursing Mothers
This study checks how much of an antibiotic called fosfomycin passes into breast milk when given intravenously to healthy nursing mothers. The goal is to understand if it's safe for breastfeeding women to receive this antibiotic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old
- You must be actively breastfeeding a healthy baby who is at least 3 months old and born at full term (no complications)
- You must be in good overall health with no serious medical conditions
- You must be willing to stop breastfeeding and discard your milk for 5 days (before, during, and after the hospital visit), and have formula or stored milk ready for your baby
- Your body mass index (BMI) must be between 18 and 35
- You must use birth control if sexually active, and not be pregnant or planning pregnancy during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.
This study measures how much of the drug zilucoplan passes into breast milk. Healthy nursing mothers who are already planning to stop breastfeeding can take part to help understand how the drug is processed.
This trial studies how drugs for tuberculosis (TB) enter breast milk and affect the mother and baby. It helps find the right dose and safety for women who are breastfeeding, even if they do not have TB themselves.
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
This study measures how much of an antibiotic called gepotidacin passes into breast milk. Researchers will give healthy breastfeeding women a single dose and collect milk samples to understand if it's safe for nursing infants.
This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.
Hear when a new Healthy Lactating Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.